Profile data is unavailable for this security.
About the company
CHC Healthcare Group is a Taiwan-based investment holding company. The Company primarily involves in the agent distribution of radiation oncology, neurology, medical image and nuclear medical, as well as dental and ophthalmological equipment and instrument. The Company also offers related maintenance and leasing services, components and consumable materials and specialty consulting services. The Company deals with medical instrument with brands as Elekta, PTW, GE, Ashland, Megin, Leica, Hillrom, Sony, Ellex and Wexler, among others. The Company is also involved in the operation of pharmacy.
- Revenue in TWD (TTM)3.73bn
- Net income in TWD341.88m
- Incorporated2009
- Employees160.00
- LocationCHC Healthcare GroupNo. 88, Xingai Road, Neihu DistrictTAIPEI 114TaiwanTWN
- Phone+886 266081999
- Fax+886 266087766
- Websitehttps://www.chcg.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHC Healthcare Group | 3.73bn | 341.88m | 8.95bn | 160.00 | 28.94 | 1.45 | 9.71 | 2.40 | 1.86 | 1.86 | 19.97 | 36.92 | 0.2753 | 4.08 | 3.97 | -- | 2.52 | 3.23 | 3.00 | 3.80 | 26.37 | 30.12 | 9.15 | 13.16 | 2.01 | 10.78 | 0.455 | 81.75 | 30.35 | 9.11 | 17.47 | 5.31 | 9.69 | 2.25 |
| SciVision Biotech Inc | 787.96m | 196.83m | 9.08bn | 64.00 | 49.73 | 5.87 | 34.92 | 11.53 | 2.67 | 2.67 | 10.33 | 22.67 | 0.3601 | 2.14 | 8.34 | -- | 9.00 | 6.67 | 10.09 | 7.41 | 74.13 | 69.94 | 24.98 | 25.00 | 2.90 | -- | 0.1739 | 79.74 | 27.93 | 16.69 | 25.53 | 15.41 | -31.16 | 12.22 |
Data as of Jun 28 2024. Currency figures normalised to CHC Healthcare Group's reporting currency: Taiwan Dollar TWD
5.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 06 Jun 2024 | 4.45m | 2.67% |
| Dimensional Fund Advisors LPas of 06 Jun 2024 | 2.20m | 1.32% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.21m | 0.72% |
| Mega International Investment Trust Co., Ltd.as of 31 Dec 2023 | 295.00k | 0.18% |
| Mellon Investments Corp.as of 06 Jun 2024 | 232.00k | 0.14% |
| American Century Investment Management, Inc.as of 06 Jun 2024 | 229.00k | 0.14% |
| CTBC Investments Co., Ltd.as of 31 Dec 2023 | 135.00k | 0.08% |
| Dimensional Fund Advisors Ltd.as of 30 Apr 2024 | 124.98k | 0.08% |
| SSgA Funds Management, Inc.as of 06 Jun 2024 | 69.00k | 0.04% |
| DFA Australia Ltd.as of 31 May 2024 | 41.60k | 0.03% |
More ▼
Data from 31 Dec 2023 - 20 Jun 2024Source: FactSet Research Systems Inc.
